The morality and ethics governing CRISPR-Cas9 patents in China.
Nature biotechnology, 34(6): 616-8 PMID 27281418 DOI 10.1038/nbt.3590
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.